Hookipa

Hookipa, reeling from Roche’s KRAS cull, lays off 30% of workforce, deprioritizes programs
Fierce Biotech
Mon, 01/29/24 - 11:24 am
Roche
Hookipa
layoffs
KRAS
Hookipa halts spending on cytomegalovirus vaccine after seeing phase 2 data
Fierce Biotech
Wed, 03/15/23 - 09:21 pm
Hookipa
CMV
vaccines
HB-101
kidney transplants
Roche, Hookipa Pharma agree $25 million deal for arenaviral immunotherapy
Pharmaphorum
Fri, 10/21/22 - 10:18 am
Roche
Hookipa
KRAS mutation
arenaviral
HB-700
Hookipa CEO waives 50% of salary in bet on brighter days
Fierce Biotech
Thu, 03/24/22 - 11:42 am
Hookipa
Joern Aldag
executive pay
Pharma CEOs
Gilead rejigs HIV immunotherapy pact, grabs a stake in biotech partner
Endpoints
Wed, 02/16/22 - 10:45 am
Gilead Sciences
HUV
Hookipa
Gilead-partnered Vienna-based immunotherapy company Hookipa makes Nasdaq debut with downsized $84M IPO
Endpoints
Thu, 04/18/19 - 10:13 am
Hookipa
Gilead Sciences
IPOs
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Yahoo/Benzinga
Sun, 04/14/19 - 03:57 pm
Wave Life Sciences
Sarepta Therapeutics
Novavax
ContraFect
Scynexis
earnings
Abbott Labs
Intuitive Surgical
Brainsway
Hookipa
Turning Point Therapeutics
IPOs
5 things to know about Hookipa Pharma ahead of its IPO
Marketwatch
Fri, 04/12/19 - 10:03 am
Hookipa
IPOs
cancer
infectious diseases
Hookipa proposes IPO as its cancer vaccines head towards the clinic
BioCentury
Fri, 03/22/19 - 10:09 pm
Hookipa
IPOs
vaccines
cancer
infectious diseases
Gilead, Hookipa pen hepatitis B, HIV research collaboration
Fierce Biotech
Wed, 06/6/18 - 09:34 am
Gilead Sciences
Hookipa
hepatitis B
HIV
vaccines
drug development
Therapeutic vaccine upstart Hookipa snags $27M round to fund PhI move
Fierce Biotech
Mon, 11/4/13 - 04:46 pm
Hookipa
vaccines